Publicacións (14) Publicacións de Daniel Carpio López

2024

  1. Clinical settings with tofacitinib in ulcerative colitis

    Revista Espanola de Enfermedades Digestivas, Vol. 116, Núm. 9, pp. 484-492

2021

  1. Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn’s disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain

    Revista Española de Enfermedades Digestivas, Vol. 113, Núm. 3, pp. 170-178

  2. Effectiveness of ustekinumab in fistulising perianal Crohn′s disease refractory or intolerant to anti-TNF

    Journal of Crohn's and Colitis, Vol. 15, Núm. Supplement_1, pp. S419-S420

2020

  1. Disfagia

    Tratado de medicina de urgencias (Ergon), pp. 215-218

2018

  1. Farmacología de la enfermedad inflamatoria intestinal.

    Enfermedad inflamatoria intestinal (Ergon), pp. 191-210

  2. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease

    Gastroenterology, Vol. 154, Núm. 5, pp. 1334-1342.e4

2016

  1. Tratamiento de la enfermedad de Crohn estenosante: la clave es la elección del paciente

    Inflamatoria: Revista oficial del grupo EIGA, Núm. 9, pp. 24-26

2014

  1. Drug trough levels and primary nonresponse to antiTNF therapy in moderate-severe Crohn disease

    Gastroenterology, Vol. 146, Núm. Suppl. 1, pp. 247

2012

  1. Tu1909 An Exome-Wide Genotyping Analysis for the Identification of Candidate Genes Associated With the Response to the Thiopurine Therapy in Inflammatory Bowel Disease Patients

    Gastroenterology, Vol. 142, Núm. 5, pp. S-875

2011

  1. New Genetic Associations Detected in an Exome-Wide Association Study for Toxicity Related to Thiopurine Treatments in Inflammatory Bowel Disease

    Gastroenterology, Vol. 140, Núm. 5, pp. S-271

2009

  1. M1130 Influence of Environmental Factors in the Severity of Inflammatory Bowel Disease

    Gastroenterology, Vol. 136, Núm. 5, pp. A-356

  2. M1161 Extraintestinal Manifestations in Inflammatory Bowel Disease. Are They Associated with More Severe Disease?

    Gastroenterology, Vol. 136, Núm. 5, pp. A-363

2008

  1. Differences in severity of IBD in patients from coastal/non coastal towns

    Gastroenterology, Vol. 134 Supp.1, Núm. 4, pp. A505

  2. P229 INFLUENCE OF RURAL/URBAN ENVIRONMENT IN THE SEVERITY OF INFLAMMATORY BOWEL DISEASE

    Journal of Crohn's and Colitis Supplements, Vol. 2, Núm. 1, pp. 72